Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA)
profiling has become a potential novel strategy for patient management in B-cell lymphoma …

Mantle cell lymphoma (MCL) is an incurable rare subtype of non-Hodgkin lymphoma and is
subject to relapse and therapeutic resistance. Molecular aberrations in MCL affect …

In this article, we broadly review the application of cfDNA analysis to the diagnosis and
management of lymphoma. We introduce the advantages of cfDNA measurement over …

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest forms of cancer. Although
drug development over the past decade has gradually improved the prognosis of PDAC, the …

The analysis of circulating tumor DNA (ctDNA) in liquid biopsy specimens has an
established role for the detection of predictive molecular alterations and acquired resistance …

Next generation sequencing (NGS) is a technology that broadens the horizon of knowledge
of several somatic pathologies, especially in oncological and oncohematological pathology …

Although next-generation sequencing (NGS) data on lymphomas require further validation
before being implemented in daily practice, the clinical application of NGS can be …

The clinical relevance of flow cytometry (FC)-based bone marrow involvement (BMI) in B cell
non-Hodgkin lymphoma (B-NHL) is not well established. We conducted a systematic review …

Introduction Chimeric antigen receptor T (CAR-T) therapy has revolutionized the treatment of
relapsed/refractory large B-cell lymphoma (LBCL). However, patients who are excluded or …

Background This study aimed to evaluate the significance of multiple tumor markers (TMs)
measurements in determining the indications for conversion surgery (CS) in the …